Search hospitals

>

Illinois

>

Mount Vernon

Good Samaritan Regional Health Center

Claim this profile

Mount Vernon, Illinois 62864

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Cancer

Conducts research for Ovarian Cancer

336 reported clinical trials

1 medical researcher

Photo of Good Samaritan Regional Health Center in Mount VernonPhoto of Good Samaritan Regional Health Center in Mount VernonPhoto of Good Samaritan Regional Health Center in Mount Vernon

Summary

Good Samaritan Regional Health Center is a medical facility located in Mount Vernon, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Good Samaritan Regional Health Center is involved with conducting 336 clinical trials across 462 conditions. There are 1 research doctors associated with this hospital, such as Jay W Carlson.

Area of expertise

1

Breast Cancer

Global Leader

Good Samaritan Regional Health Center has run 64 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
ER positive
HER2 negative
2

Lung Cancer

Global Leader

Good Samaritan Regional Health Center has run 47 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Good Samaritan Regional Health Center

Bladder Cancer

Lung Cancer

Breast Cancer

Prostate Cancer

Breast cancer

Esophageal cancer

Multiple Myeloma

Melanoma

Cancer

Pancreatic Cancer

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Good Samaritan Regional Health Center?

Where is Good Samaritan Regional Health Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Good Samaritan Regional Health Center accept?

What awards or recognition has Good Samaritan Regional Health Center received?